Related scientific articles (all)

How to deal with micronutrient product shortage - Editorial.

Authors : Joly F, Mundi M, Barazzoni R, Berger MM, Bozzetti F, Cuerda C, Jeppesen PB, Lal S, Lamprecht G, Szczepanek K, Van Gossum A, Schneider S, Shenkin A, Wanten G, Pironi L
Year : 2023
Journal : Clin Nutr
Volume : 42
Pages : 143-147

Optimizing multiparametric magnetic resonance imaging-targeted biopsy and prostate cancer grading accuracy.

Authors : Diamand R, Peltier A, Roche JB, Lievore E, Lacetera V, Chiacchio G, Beatrici V, Mastroianni R, Simone G, Windisch O, Benamran D, Fourcade A, Nguyen TA, Fournier G, Fiard G, Ploussard G, Roumeguère T, Albisinni S
Year : 2023
Journal : World J Urol
Volume : 41
Pages : 77-84

Erratum to When targeted therapy for cancer leads to ICU admission. RETRO-TARGETICU multicentric study" [Bull. Cancer 109 (2022) 916-24]."

Authors : Meert AP, Toffart AC, Picard M, Jaubert P, Gibelin A, Bauer P, Mokart D, Van de Louw A, Hatzl S, Moreno-Gonzales G, Rousseau-Bussac G, Bruneel F, Montini L, Moreau AS, Carpentier D, Seguin A, Hemelaar P, Azoulay E, Lemiale V
Year : 2023
Journal : Bull Cancer

Role of the Prostate Imaging Quality PI-QUAL Score for Prostate Magnetic Resonance Image Quality in Pathological Upstaging After Radical Prostatectomy: A Multicentre European Study.

Authors : Windisch O, Benamran D, Dariane C, Favre MM, Djouhri M, Chevalier M, Guillaume B, Oderda M, Gatti M, Faletti R, Colinet V, Lefebvre Y, Bodard S, Diamand R, Fiard G
Year : 2023
Journal : Eur Urol Open Sci
Volume : 47
Pages : 94-101

Linking clinical and population-based data in older patients with cancer in Belgium: Feasibility and clinical outcomes.

Authors : Depoorter V, Vanschoenbeek K, Decoster L, De Schutter H, Debruyne PR, De Groof I, Bron D, Cornélis F, Luce S, Focan C, Verschaeve V, Debugne G, Langenaeken C, Van den Bulck H, Goeminne JC, Teurfs W, Jerusalem G, Schrijvers D, Petit B, Rasschaert M, Praet JP, Vandenborre K, Milisen K, Flamaing J, Kenis C, Verdoodt F, Wildiers H
Year : 2023
Journal : J Geriatr Oncol
Pages : 101428

Ten-year survival of neoadjuvant dual HER2 blockade in patients with HER2-positive breast cancer.

Authors : Nuciforo P, Townend J, Piccart-Gebhart M, Fielding S, Gkolfi P, El-Abed S, de Azambuja E, Werutsky G, Bliss J, Moebus V, Colleoni M, Aspitia AM, Gomez H, Gombos A, Coccia-Portugal MA, Tseng LM, Kunz G, Lerzo G, Sohn J, Semiglazov V, Saura C, Kroep J, Ferro A, Cameron D, Gelber R, Huober J, Di Cosimo S
Year : 2023
Journal : Eur J Cancer
Volume : 181
Pages : 92-101

Risk stratification for early biochemical recurrence of prostate cancer in the era of multiparametric magnetic resonance imagining-targeted biopsy.

Authors : Diamand R, Peltier A, Roche JB, Lievore E, Lacetera V, Chiacchio G, Beatrici V, Mastroianni R, Simone G, Windisch O, Benamran D, Fourcade A, Nguyen TA, Fournier G, Fiard G, Ploussard G, Roumeguère T, Albisinni S
Year : 2023
Journal : Prostate

How I treat endocrine-dependent metastatic breast cancer.

Authors : Gombos A, Goncalves A, Curigliano G, Bartsch R, Kyte JA, Ignatiadis M, Awada A
Year : 2023
Journal : ESMO Open
Volume : 8
Pages : 100882

Streamlining clinical research: an ESMO awareness call to improve sponsoring and monitoring of clinical trials.

Authors : Perez-Gracia JL, Penel N, Calvo E, Awada A, Arkenau HT, Amaral T, Grünwald V, Sanmamed MF, Castelo-Branco L, Bodoky G, Lolkema MP, Di Nicola M, Casali P, Giuliani R, Pentheroudakis G
Year : 2023
Journal : Ann Oncol
Volume : 34
Pages : 70-77

Impact of Anti-HER2 Therapy Alone and With Weekly Paclitaxel on the Ovarian Reserve of Young Women With HER2-Positive Breast Cancer.

Authors : Lambertini M, Ceppi M, Anderson RA, Cameron DA, Bruzzone M, Franzoi MA, Massarotti C, El-Abed S, Wang Y, Lecocq C, Nuciforo P, Rolyance R, Pusztai L, Sohn J, Latocca MM, Arecco L, Pistilli B, Ruddy KJ, Ballestrero A, Del Mastro L, Peccatori FA, Partridge AH, Saura C, Untch M, Piccart-Gebhart M, Di Cosimo S, de Azambuja E, Demeestere I
Year : 2023
Journal : J Natl Compr Canc Netw
Volume : 21
Pages : 33-41.e16

Understanding biochemical recurrence after radical prostatectomy: trust biology, not a number.

Authors : Albisinni S, Diamand R
Year : 2023
Journal : Prostate Cancer Prostatic Dis

Teaching robotic cystectomy: Prospective pilot clinical validation of the ERUS training Curriculum.

Authors : Diamand R, DHondt F, Mjaess G, Jabbour T, DellOglio P, Larcher A, Moschini M, Quackels T, Peltier A, Assenmacher G, Wiklund P, Breda A, Turri F, De Groote R, Mottrie A, Roumeguere T, Albisinni S
Year : 2023
Journal : BJU Int

ASO Author Reflections: Preoperative Serological Biomarkers as Novel Prognostic Factors in Patients with Peritoneal Metastases of Colorectal Cancer Origin.

Authors : El Asmar A, Liberale G
Year : 2023
Journal : Ann Surg Oncol
Volume : 30
Pages : 1870-1871

Medical oncology education in Europe: equipping medical oncologists to provide the best care for patients with cancer.

Authors : Jordan K, de Azambuja E, Amaral T, Strijbos M, Curigliano G, Lordick F
Year : 2023
Journal : Oncol Res Treat

Anaplastic thyroid carcinoma: advances in molecular profiling and targeted therapy.

Authors : Jungels C, Pita JM, Costante G
Year : 2023
Journal : Curr Opin Oncol
Volume : 35
Pages : 1-9

Improving emotion regulation in breast cancer patients in the early survivorship period: Efficacy of a brief ecologically boosted group intervention.

Authors : Merckaert I, Waroquier P, Caillier M, Verkaeren O, Righes S, Liénard A, Libert Y, Kristanto P, Razavi D
Year : 2023
Journal : Psychooncology

Monomorphic epitheliotropic intestinal T-cell lymphoma comprises morphologic and genomic heterogeneity impacting outcome.

Authors : Veloza L, Cavalieri D, Missiaglia E, Ledoux-Pilon A, Bisig B, Pereira B, Bonnet C, Poullot E, Quintanilla-Martinez L, Dubois R, Llamas-Gutierrez F, Bossard C, de Wind R, Drieux F, Fontaine J, Parrens M, Sandrini J, Fataccioli V, Delfau-Larue MH, Daniel A, Lhomme F, Clément-Filliatre L, Lemonnier F, Cairoli A, Morel P, Glaisner S, Joly B, El Yamani A, Laribi K, Bachy E, Siebert R, Vallois D, Gaulard P, Tournilhac O, de Leval L
Year : 2023
Journal : Haematologica
Volume : 108
Pages : 181-195

Immunotherapy in breast cancer: an overview of current strategies and perspectives.

Authors : Debien V, De Caluwé A, Wang X, Piccart-Gebhart M, Tuohy VK, Romano E, Buisseret L
Year : 2023
Journal : NPJ Breast Cancer
Volume : 9
Pages : 7

Cardiac safety of dual anti-HER2 blockade with pertuzumab plus trastuzumab in early HER2-positive breast cancer in the APHINITY trial.

Authors : de Azambuja E, Agostinetto E, Procter M, Eiger D, Pondé N, Guillaume S, Parlier D, Lambertini M, Desmet A, Caballero C, Aguila C, Jerusalem G, Walshe JM, Frank E, Bines J, Loibl S, Piccart-Gebhart M, Ewer MS, Dent S, Plummer C, Suter T
Year : 2023
Journal : ESMO Open
Volume : 8
Pages : 100772

Sepsis-associated coagulopathy in onco-hematology patients presenting with thrombocytopenia: a multicentric observational study.

Authors : Lemiale V, Mabrouki A, Miry L, Mokart D, Pène F, Kouatchet A, Mayaux J, Bruneel F, Perez P, Meert AP, Moreau AS, Benoit D, Darmon M, Zafrani L, Clere-Jehl R
Year : 2023
Journal : Leuk Lymphoma
Volume : 64
Pages : 197-204